EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guazuma ulmifolia butanol extract protects against cadmium-induced hepatotoxicity via HO-1/Sirt-1 activation, miRNA–lncRNA modulation, and metabolic reprogramming

Osama Ahmed Elsabagh, Abdelbaset M Elgamal, Heba A Hassan, Naglaa M Ammar, Zeinab A El-Gendy, Mohamed A El-Saied, Mawada Mohamed Ali, Reham S Ibrahim, Ahmed H El-Desoky, Emad M Hassan, Mohamed A Farag, Abdelsamed I Elshamy iD

PLOS One · 06.08.2026 · 21 (8) · e0355464

DOI: 10.1371/journal.pone.0355464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.08.2026. Verfasst von Osama Ahmed Elsabagh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacognosy Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Cairo, Egypt. Hauptthemen laut MEDLINE: Plant Extracts, Sirtuin 1, MicroRNAs, Cadmium. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guazuma ulmifolia is traditionally used for liver disorders, but its protective mechanisms against heavy metal toxicity are poorly defined. This study evaluated the phytochemical profile and hepatoprotective mechanisms of G. ulmifolia butanol extract (Gul-BuOH) against cadmium-induced liver injury. Methods and findings Gul-BuOH was chemically profiled by UPLC-PDA-ESI–qTOF-MS/MS. Cadmium hepatotoxicity was induced in rats, followed by Gul-BuOH treatment (100 and 200 mg/kg). Liver injury, oxidative stress, inflammation, gene expression (Let-7a, HOTAIR), histopathology, HO-1/Sirt-1 immunoreactivity, and serum metabolomic changes were assessed. Chemical profiling led to the annotation of 42 compounds, including mainly flavonoids and phenolic acids, highlighting the rich phytochemical composition of G. ulmifolia . CdCl 2 exposure increased hepatic Cd accumulation and elevated ALT, AST, and ALP, reduced TAC, and increased NO and MDA. Gul-BuOH significantly reduced hepatic Cd levels by 2.6- and 3.2-fold, restored TAC by 38.3% and 83.2%, and decreased NO (56.3% and 63.4%) and MDA (45.4% and 54.6%) at 100 and 200 mg/kg, respectively. Inflammatory markers NF-κB-p and TNF-α were markedly suppressed, while miRNA Let-7a was upregulated and lncRNA HOTAIR was downregulated. Histological and immunohistochemical analyses revealed near-complete restoration of hepatic architecture and normalization of HO-1 and Sirt-1 expression at the high dose. Serum metabolomics’ OPLS-DA model performance indicators demonstrated strong reliability, with an R 2 Y (explained variance) of 0.991 and a Q 2 (predictive variance) of 0.988). The model identified 36 significantly altered metabolites that were largely normalized by Gul-BuOH, implicating linoleic acid metabolism, amino acid biosynthesis, and ascorbate-related pathways.

Conclusion

Gul-BuOH affords dose-dependent protection against Cd-induced liver injury by modulating oxidative stress, inflammation, metal detoxification, and metabolic pathways, supporting the traditional use of G. ulmifolia and its potential as a multi-target hepatoprotective agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsSirtuin 1MicroRNAsCadmiumChemical and Drug Induced Liver InjuryHeme Oxygenase-1Protective AgentsAnimalsRatsOxidative StressMaleLiver

Substanzen

Plant ExtractsSirtuin 1MicroRNAsCadmiumHeme Oxygenase-1Protective Agents

Autor:innen und Institutionen

  • Pharmacognosy Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Cairo, Egypt.
  • Department of Chemistry of Microbial and Natural Products, Pharmaceutical and Drugs Research Institute, National Research Centre, Giza, Egypt.
  • Therapeutic Chemistry Department, National Research Centre, Dokki, Giza, Egypt.
  • Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt.
  • Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
  • Department of Pathology, Faculty of Veterinary Medicine, King Salman International University (KSIU).

ORCID-Profile: Abdelsamed I Elshamy

Zitieren

APA

Elsabagh, O. A., Elgamal, A. M., Hassan, H. A., Ammar, N. M., El-Gendy, Z. A., El-Saied, M. A., Ali, M. M., Ibrahim, R. S., El-Desoky, A. H., Hassan, E. M., Farag, M. A., & Elshamy, A. I. (2026). Guazuma ulmifolia butanol extract protects against cadmium-induced hepatotoxicity via HO-1/Sirt-1 activation, miRNA–lncRNA modulation, and metabolic reprogramming. PLOS One, 21(8), e0355464. https://doi.org/10.1371/journal.pone.0355464

Vancouver

Elsabagh OA, Elgamal AM, Hassan HA, Ammar NM, El-Gendy ZA, El-Saied MA, et al. Guazuma ulmifolia butanol extract protects against cadmium-induced hepatotoxicity via HO-1/Sirt-1 activation, miRNA–lncRNA modulation, and metabolic reprogramming. PLOS One. 2026;21(8):e0355464. doi:10.1371/journal.pone.0355464

BibTeX
@article{Elsabagh2026,
  author = {Elsabagh, Osama Ahmed and Elgamal, Abdelbaset M and Hassan, Heba A and Ammar, Naglaa M and El-Gendy, Zeinab A and El-Saied, Mohamed A and Ali, Mawada Mohamed and Ibrahim, Reham S and El-Desoky, Ahmed H and Hassan, Emad M and Farag, Mohamed A and Elshamy, Abdelsamed I},
  title = {Guazuma ulmifolia butanol extract protects against cadmium-induced hepatotoxicity via HO-1/Sirt-1 activation, miRNA–lncRNA modulation, and metabolic reprogramming},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0355464},
  doi = {10.1371/journal.pone.0355464}
}
Kostenlos starten →